Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Telo Genomics Corp

TELO.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$0.03

▲ +14.29%

Market Cap $2.91M · Vol 102.00K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.91M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

33.33

Momentum

Beta

0.19

vs Market

52W High

$0.07

57.34% below

52W Low

$0.03

17.24% above

Volume

102.00K

Avg 24.31K

P/B

21.36

Price-to-book

ROE

N/A

Return on equity

Free Float

97.02%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Telo Genomics Corp (TELO.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TELO.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-11.11%

-38.46%

-11.11%

YTD

-20.00%

-46.67%

-86.86%

-91.40%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-1,998,052.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-289.70% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	21.36
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	100.43M

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.04
RSI (14)	33.33
Beta	0.19
52-Week High	$0.07
52-Week Low	$0.03

Volume Today	102.00K
Avg Daily Volume (30D)	24.31K
Relative Volume	4.20x
Volatility (10D)	117.96
Volatility (30D)	113.59
Free Float	97.02%

Analyst Consensus

N/A

Current Price $0.03

Mean Target N/A

52W Low$0.03 52W High$0.07

Current

Target

$0.03 $0.07

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG0025YXNQ0

ISINCA87975M2085

CountryCanada

Sub-IndustryBio Diagnostics & Testing

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

IOVA Iovance Biotherapeutics Inc +1.03% ADPT Adaptive Biotechnologies Corp -1.18% VCYT Veracyte Inc -4.79% CDNA CareDx Inc +2.05% 300676.SZ BGI Genomics Co Ltd -1.65%

Company Profile

Telo Genomics Corp. is a molecular diagnostics company that is engaged in developing the telomere analysis platform Teloview to enable the development of diagnostic and prognostic applications based on the quantification of genomic instability as a disease predictor. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. It quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.